Location History:
- Berlin, DE (2003)
- Schwanebeck, DE (2007 - 2010)
- Panketal, DE (2022)
Company Filing History:
1 out of 21 
1 out of 1 
1 out of 30 Years Active: 2003-2022
Title: Ulrike Stein: Innovator in Cancer Treatment
Introduction
Ulrike Stein is a prominent inventor based in Schwanebeck, Germany, known for her significant contributions to cancer research and treatment. With a total of four patents to her name, she has made remarkable strides in the field of oncology.
Latest Patents
One of her latest patents is focused on the use of niclosamide for the treatment of cancer metastasis. This innovative method involves identifying subjects with elevated levels of S100A4 transcription and administering a therapeutically effective amount of niclosamide or its derivatives. The treatment aims to inhibit or reduce the risk of cancer metastasis by targeting specific transcription levels. Another notable patent is related to the nucleic acid sequence encoding for the polypeptide of 7a5/Prognostin. This invention is particularly relevant for tumor diagnostics and therapy, especially for metastasizing tumors.
Career Highlights
Ulrike has worked with esteemed institutions such as the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité - Universitätsmedizin Berlin. Her work in these organizations has significantly advanced the understanding and treatment of cancer.
Collaborations
Throughout her career, Ulrike has collaborated with notable professionals in her field, including Wolfgang Walther and Peter Michael Schlag. These collaborations have further enriched her research and innovations.
Conclusion
Ulrike Stein's contributions to cancer treatment through her patents and research highlight her as a leading figure in the field of oncology. Her innovative approaches continue to pave the way for advancements in cancer diagnostics and therapy.